Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.52 |
| ▸ | PNMT | P11086 | 2/20 | 0.46 |
| ▸ | MAOB | P27338 | 2/20 | 0.46 |
| ▸ | IDO1 | P14902 | 2/20 | 0.43 |
| ▸ | LOXL2 | Q9Y4K0 | 2/20 | 0.41 |
| ▸ | HTR2C | P28335 | 1/20 | 0.41 |
| ▸ | HTR2B | P41595 | 1/20 | 0.41 |
| ▸ | DPP4 | P27487 | 1/20 | 0.39 |
| ▸ | CES2 | O00748 | 1/20 | 0.39 |
| ▸ | BCHE | P06276 | 1/20 | 0.39 |
| ▸ | CES1 | P23141 | 1/20 | 0.39 |
| ▸ | MPO | P05164 | 2/20 | 0.39 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.39 |
| ▸ | HTR2A | P28223 | 1/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.38 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2210035 | 0.85 | TAAR1 (0.67) | TAAR1MAOBIDO1MPOHTR2A | |
| SCHEMBL31061956 | 0.85 | TAAR1 (0.67) | TAAR1MAOBIDO1MPOHTR2A | |
| Hydrochloric Acid SCHEMBL2211422 | 0.83 | TAAR1 (0.64) | TAAR1MAOBIDO1HTR2CHTR2B | |
| SCHEMBL10476233 | 0.83 | MAOB (0.50) | TAAR1MAOBIDO1LOXL2MPO | |
| SCHEMBL7052559 | 0.81 | TAAR1 (0.48) | TAAR1IDO1CES2BCHECES1 | |
| SCHEMBL3300692 | 0.81 | MPO (0.47) | TAAR1IDO1CES2BCHECES1 | |
| SCHEMBL6621 | 0.81 | — | — | |
| SCHEMBL30556230 | 0.81 | — | — | |
| SCHEMBL3672443 | 0.80 | TAAR1 (0.48) | TAAR1PNMTMAOBIDO1LOXL2 | |
| SCHEMBL14354164 | 0.80 | TAAR1 (0.48) | TAAR1PNMTMAOBIDO1LOXL2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 512 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025137551-A1 | AMINE PURIFICATION IN A CARBON CAPTURE METHOD USING MOF BODIES | SCHLUMBERGER TECHNOLOGY CORPORATION (US) | 2025-06-26 | — | — | WO | claimed |
| CN-119140080-B | Titanium oxide film catalytic material for rapid high-yield synthesis of imine and preparation method and application thereof | 中国科学院理化技术研究所 | 2025-02-11 | — | — | CN | claimed |
| CN-119140080-A | Titanium oxide film catalytic material for rapid high-yield synthesis of imine and preparation method and application thereof | 中国科学院理化技术研究所 | 2024-12-17 | — | — | CN | claimed |
| CN-105505128-B | Near-infrared light response self-repairing coating and preparation method thereof | 南京工业大学 | 2018-05-08 | — | — | CN | claimed |
| EP-2819766-B1 | REMOVING SULPHUR OXIDES FROM A FLUID STREAM | BASF SE (DE) | 2016-05-18 | — | — | EP | claimed |
| CN-105505128-A | Near-infrared light response self-repairing coating and preparation method thereof | NANJING UNIVERSITY OF TECHNOLOGY | 2016-04-20 | — | — | CN | claimed |
| CN-103848806-B | Glucopyranosyl derivatives, its preparation method and in application pharmaceutically | SUNSHINE LAKE PHARMA CO.,LTD. (CN) | 2016-04-06 | — | — | CN | claimed |
| EP-2819766-A1 | REMOVING SULPHUR OXIDES FROM A FLUID STREAM | BASF SE (DE) | 2015-01-07 | — | — | EP | claimed |
| US-20130259789-A1 | REMOVING SULPHUR OXIDES FROM A FLUID STREAM | RESEARCH TRIANGLE INSTITUTE (US) | 2013-10-03 | — | — | US | claimed |
| WO-2013128001-A1 | REMOVING SULPHUR OXIDES FROM A FLUID STREAM | BASF SE (DE) | 2013-09-06 | — | — | WO | claimed |
| WO-2010139288-A1 | 5,7-DISUBSTITUTED 3-ISOPROPYLPYRAZOLO[4,3-D]PYRIMIDINES FOR USE AS MEDICAMENTS AND PHARMACEUTICAL COMPOSITIONS | C3 BIO GMBH (DE) | 2010-12-09 | — | — | WO | claimed |
| US-20100029655-A1 | Processes For The Preparation Of Anti-Viral Compounds And Compositions Containing Them | LEIVERS MARTIN ROBERT | 2010-02-04 | — | — | US | claimed |
| WO-2010006096-A1 | PROCESSES FOR THE PREPARATION OF ANTI-VIRAL COMPOUNDS AND COMPOSITIONS CONTAINING THEM | SMITHKLINE BEECHAM CORPORATION (US) | 2010-01-14 | — | — | WO | claimed |
| EP-2006271-A9 | SUBSTITUTED BICYCLIC CYCLIC DERIVATIVE AND USE THEREOF | Asahi Kasei Pharma Corporation (JP) | 2009-07-29 | — | — | EP | claimed |
| US-20090054401-A1 | Substituted bicyclic derivatives and use thereof | ASAHI KASEI PHARMA CORPORATION (JP) | 2009-02-26 | — | — | US | claimed |
| EP-2006271-A2 | SUBSTITUTED BICYCLIC CYCLIC DERIVATIVE AND USE THEREOF | Asahi Kasei Pharma Corporation (JP) | 2008-12-24 | — | — | EP | claimed |
| US-12606541-B2 | PPARg modulators and methods of use | EISAI R&D MANAGEMENT CO., LTD. (JP) | 2026-04-21 | — | — | US | disclosed |
| EP-4689155-A1 | USE OF INHIBITORS TO INCREASE EFFICIENCY OF CRISPR/CAS INSERTIONS | Astrazeneca AB (SE) | 2026-02-11 | — | — | EP | disclosed |
| WO-1999012912-A1 | THIOUREA DERIVATIVES OR NON-TOXIC SALTS THEREOF FOR INHIBITNG RAS-TRANSFORMED CELL GROWTH | YUHAN CORPORATION (KR) | 1999-03-18 | — | — | WO | disclosed |
| WO-1998045268-A1 | NICOTINAMIDE DERIVATIVES | PFIZER PRODUCTS INC. (US) | 1998-10-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090054401-A1 | Substituted bicyclic derivatives and use thereof | LTB4R2, LTC4S, LTB4R | TAAR1 1127/4885PNMT 3102/4885MAOB 880/4885 |
| US-12606541-B2 | PPARg modulators and methods of use | PPARG, PPARA, PPARD | TAAR1 786/4885PNMT 4606/4885MAOB 2170/4885 |
| US-20100029655-A1 | Processes For The Preparation Of Anti-Viral Compounds And Compositions Containing Them | RPL35, HAVCR2, RPL5 | TAAR1 4722/4885PNMT 3359/4885MAOB 947/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.